Suman Mitra

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suman Mitra. Retrieved from https://idiyas.com/inventor/suman-mitra-4jar27mv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suman Mitra: Innovator in Anti-Tumor Therapy

Introduction

Suman Mitra is a notable inventor recognized for his contributions to the field of cancer research. He has developed innovative solutions aimed at enhancing anti-tumor activity, which could significantly impact cancer treatment.

Latest Patents

Mitra holds a patent for "T Cells Having Enhanced Anti-Tumor Activity." This patent represents a significant advancement in the use of T cells for therapeutic purposes, potentially leading to more effective cancer treatments.

Career Highlights

Suman Mitra works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization underscores his commitment to advancing public health through innovative research.

Collaborations

Mitra has collaborated with notable colleagues, including Warren Jaye Leonard and Luca Gattinoni. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving groundbreaking results.

Conclusion

Suman Mitra's work in enhancing anti-tumor therapies through innovative patents exemplifies the vital role of inventors in the fight against cancer. His contributions are paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…